Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from

M M Tabbers1, C DiLorenzo, M Y Berger

  • 1Emma Children's Hospital/Academic Medical Center, Amsterdam, The Netherlands.

Insights

This study provides evidence-based guidelines for evaluating and managing pediatric functional constipation. It offers standardized recommendations and algorithms for infants and children to improve care quality.

Area of Science:

  • Pediatric Gastroenterology
  • Evidence-Based Medicine

Background:

  • Functional constipation is a common pediatric issue requiring standardized management.
  • The North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) developed evidence-based guidelines.

Purpose of the Study:

  • To create uniform, evidence-based guidelines for the evaluation and management of functional constipation in children.
  • To standardize and improve the quality of care for pediatric patients with constipation.

Main Methods:

  • Formulated nine clinical questions covering diagnosis, treatment, and prognosis.
  • Conducted a systematic literature search (inception-October 2011) across multiple databases (Embase, MEDLINE, Cochrane, PsychInfo).
  • Applied the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system and Oxford Centre for Evidence-Based Medicine criteria to assess evidence quality; recommendations finalized through consensus meetings and voting.

Main Results:

  • Developed evidence-based recommendations for evaluating and treating pediatric functional constipation.
  • Created two distinct algorithms: one for infants under 6 months and another for older infants and children.

Conclusions:

  • The guidelines aim to standardize daily practice and serve as a foundation for future research in pediatric constipation.
  • Highlights the need for large, well-designed clinical trials for diagnostic evaluation and treatment strategies.
Abstract

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.4K
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
989
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
907
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
1.4K
Assessment of the Gastrointestinal System II: Health Perception Pattern01:29

Assessment of the Gastrointestinal System II: Health Perception Pattern

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
636
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
1.1K